BIND Therapeutics to Report Third Quarter 2013 Financial Results and Business Developments on November 5, 2013
Published: Oct 29, 2013
BIND Therapeutics, Inc. (NASDAQ: BIND) a clinical-stage nanomedicine platform company developing targeted and programmable therapeutics called AccurinsTM, announced today that it will report financial results for the third quarter ended September 30, 2013 on Tuesday, November 5, 2013. BIND’s management team will host a conference call and audio webcast at 8:30 a.m., Eastern Time, on Tuesday, November 5, 2013 to discuss the quarterly results and recent business developments.
Help employers find you! Check out all the jobs and post your resume.